Biological stock: subsidiary approved to produce emergency foot-and-mouth disease vaccine for immunization.

The biological company announced that its fully-owned subsidiary, Jinyu Bao Ling Biopharmaceutical Co., Ltd., has been approved to produce emergency immunization foot-and-mouth disease South Africa 1 type subunit vaccine and foot-and-mouth disease South Africa 1 type inactivated vaccine. The company will actively cooperate with national epidemic prevention policies, accelerate the progress of emergency immunization work, strictly organize production in accordance with relevant requirements, and ensure the quality of the vaccines. This vaccine is approved for emergency use, and there is uncertainty about whether it can smoothly obtain formal production approval in the future. The company will steadily promote production guarantee work, and kindly remind investors to pay attention to investment risks.